What this means
This review summarizes earlier work on NAD+, a chemical that helps cells make energy. Its levels fall with age and are lower in the brains of people with Parkinson's.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- A review of earlier studies, including animal and early human studies
- Kind of research
- A summary of earlier studies
The science
- Original title
- NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives.
- Authors
- Wang T, Zhou X, Chen X
- Journal
- Frontiers in neurology
- Published
- Oct 15, 2026
- Study type
- Review · in humans
- PMID
- 42877680 ↗
Abstract
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder worldwide, characterized by the progressive loss of dopaminergic neurons in the substantia nigra, accumulation of α-synuclein (α-syn), mitochondrial dysfunction, and neuroinflammation. Nicotinamide adenine dinucleotide (NAD+), a crucial coenzyme involved in cellular energy metabolism, DNA repair, and epigenetic regulation, declines with aging and is markedly reduced in the brains of patients with PD. Emerging evidence suggests that supplementation with NAD+ precursors, including nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), exerts neuroprotective effects through multiple mechanisms, such as activation of the mitochondrial unfolded protein response (UPR∧mt), enhancement of autophagy, and suppression of excessive poly(ADP-ribose) polymerase 1 (PARP1) activation. This review summarizes the central role of NAD+ dysregulation in the pathogenesis of PD, with particular emphasis on the interplay between NAD+ depletion, mitochondrial quality control, proteostasis, and neuroinflammation. Furthermore, we discuss recent advances in NAD+-boosting strategies in PD models and clinical studies, highlighting their potential therapeutic implications for PD intervention.
Wang T, Zhou X, Chen X NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives. Frontiers in neurology. 2026. doi:10.3389/fneur.2026.1943801. PMID: 42877680. https://pubmed.ncbi.nlm.nih.gov/42877680/
Related research
Trained older adults showed muscle changes that looked more like those of younger adults
Researchers studied muscle from younger and older people, some fit and some less fit, before and after one bout of exercise. Half of the age-related muscle differences were missing in trained older adults.
Immune cells in aging bone marrow and how they affect bone loss in mice
Researchers found a signal in bone marrow immune cells that links fat buildup to weaker bone formation. Blocking it with NMN in mice reduced bone loss, but this does not show the same happens in people.
See all research on NAD+ boosters →